Top News Stories
News
GLP-1 drugs need price cuts to be financially viable, researchers say
By Allison BellZepbound could add a quality-adjusted life year for $100,000 when the annual cost falls to $4,334.
Zepbound could add a quality-adjusted life year for $100,000 when the annual cost falls to $4,334.